Edition:
United States

United Therapeutics Corp (UTHR.OQ)

UTHR.OQ on NASDAQ Stock Exchange Global Select Market

131.69USD
2:50pm EST
Change (% chg)

$-5.04 (-3.69%)
Prev Close
$136.73
Open
$134.38
Day's High
$134.38
Day's Low
$129.21
Volume
183,209
Avg. Vol
228,856
52-wk High
$163.75
52-wk Low
$97.70

UTHR.OQ

Chart for UTHR.OQ

About

United Therapeutics Corporation is a biotechnology company. The Company is focused on the development and commercialization of products for the treatment of chronic and life-threatening conditions. Its therapeutic products and product candidates include Prostacyclin Analogues, Phosphodiesterase Type 5 (PDE-5) Inhibitor and... (more)

Overall

Beta: 1.36
Market Cap(Mil.): $5,799.47
Shares Outstanding(Mil.): 42.42
Dividend: --
Yield (%): --

Financials

  UTHR.OQ Industry Sector
P/E (TTM): 9.22 42.12 30.77
EPS (TTM): 14.84 -- --
ROI: 39.82 -0.81 15.23
ROE: 42.54 -1.52 16.56

BRIEF-United Therapeutics reports Q3 EPS $3.50

* United therapeutics corporation reports third quarter 2016 financial results

Oct 27 2016

Competitors

Earnings vs. Estimates